Pipercuronium bromide amp. 4 mg/2 ml

This tender concerns the procurement of Pipercuronium bromide, specifically in ampoules of 4 mg/2 ml. The generic (international non-proprietary) name for the substance is Pipercuronium bromide. The unit of measure for this procurement is 'piece' (брой). The estimated quantity required over a two-year period is 150 units. This tender is likely for a healthcare institution or a pharmaceutical supplier seeking to acquire this specific medication. Pipercuronium bromide is a neuromuscular blocking agent used in anesthesia to facilitate endotracheal intubation and provide skeletal muscle relaxation during surgical procedures. The tender specifies the exact dosage and form, indicating a need for a precise pharmaceutical product. Interested bidders should ensure their offerings meet these exact specifications. Further details regarding delivery timelines, quality standards, and submission deadlines would typically be found in the full tender documentation. The procurement focuses on a single, well-defined pharmaceutical product, suggesting a straightforward acquisition process for this essential medication.

This is a supplies contract in the health and medical services sector, with a focus on Medical Equipment and Pharmaceuticals. Located in Bulgaria, Europe, this opportunity is open to firms and consortiums, with an estimated budget of BGN 630.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.